Page 6 - Zydus Cadila

Zydus Cadila gets tentative US FDA approval for generic diabetes drug

Drug firm Zydus Cadila said it has received approval from the US health regulator to market diabetes drug, Empagliflozin and Linagliptin tablets, in the US market

Zydus Cadila gets approval from USFDA for muscle relaxant injection

Drugfirm Zydus Cadila has received final approval from the US health regulator to market Cisatracurium BesylateInjection, a muscle relaxant given before general anaesthesia

Zydus Wellness board approves fund-raising of up to Rs 1,100 crore

As of quarter ended June 30, 2020, Zydus Family Trust held 4.29 per cent stake in Zydus Wellness

Covid-19: At Rs 2,800 per dose, Zydus launches cheapest remdesivir brand

Zydus plans to supply large quantities of the injectable drug in the market soon

Zydus Cadila gets USFDA nod to market phosphorus controlling drug

Drug firm Zydus Cadila on Thursday said it has received final nod from the US health regulator to market generic Sevelamer Carbonate tablets

Zydus launches cheapest remdesivir at Rs 2,800 per 100 mg vial in India

Potential Covid-19 treatment drug launched under brand name Remdac in India

Zydus Cadila launches India's 'cheapest' remdesivir at Rs 2,800 per vial

Zydus is the fifth company to launch a copy of the antiviral in India after privately held Hetero Labs Ltd, Cipla, Mylan NV and Jubilant Life Sciences Ltd

Zydus Cadila to begin phase II Covid-19 vaccine clinical trials from Aug 6

Zydus Cadila Chairman Pankaj R Patel said the phase I dosing to establish the safety of ZyCoV-D is an important milestone

Zydus Cadila gets tentative USFDA nod to market Parkinson's disease drug

The drug will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad

Zydus gets USFDA nod for drug trials to treat chemotherapy-induced anemia

Drug firm Zydus Cadila on Thursday said it has received approval from the US health regulator to initiate clinical trials for its drug 'Desidustat' in treatment of chemotherapy-induced anemia

Zydus Cadila gets USFDA nod to market generic drug to treat headache

The drug will be manufactured at Nesher Pharma's manufacturing facility at St. Louis in the US, the drug firm says

Zydus gets nod from Mexican authority for Covid-19 therapy clinical trials

Drug firm Zydus Cadila said it has received approval from Mexico's regulatory authority Cofepris to conduct clinical trials with its biological therapy "Pegylated Interferon alpha-2b"

Human trials of Covid-19 vaccine a milestone for Atmanirbhar Bharat: DBT

Zydus Cadila on Wednesday said it has initiated Phase 1 and 2 clinical trials of its Covid-19 vaccine candidate

Zydus Cadila begins human trials for its Covid-19 vaccine candidate

ZyCoV-D will be second Indian-origin vaccine candidate to go into human trials.

Zydus gets Mexican regulator's approval for coronavirus drug study

Desidustat tablets to be tested for the management of coronavirus patients-the first such approval

Covaxin, ZyCov-D trails mark 'beginning of the end' of Covid-19: Scientist

The article has been published on the websites of the Press Information Bureau (PIB) and the Vigyan Prasar, which is a body under the ministry

Covid-19 crisis: Race to develop vaccine gets a booster as field widens

On Thursday, CDSCO also approved Zydus Cadila's plasmid DNA vaccine candidate ZyCoV-D, developed at its Vaccine Technology Centre in Ahmedabad.

Now, Zydus Cadila gets DCGI nod for human trials of Covid vaccine

Zydus Cadila has already successfully completed preclinical phase for its plasmid DNA vaccine candidate ZyCoV-D developed indigenously at its Vaccine Technology Centre in Ahmedabad

Regulator allows Zydus Cadila human clinical trials of Covid-19 vaccine

The assent for human trials was given after the company submitted data of clinical trial on animals to the DCG

Zydus Cadila gets USFDA nod to market generic antihistamine tablets

The drug will be manufactured at the group's manufacturing facility in Ahmedabad